Dynamics of disease progression during treatment with Osimertinib in patients with EGFR T790M‐positive non‐small cell lung cancer

BACKGROUND: Patterns of treatment failure and subsequent treatment in non‐small cell lung cancer (NSCLC) patients treated with osimertinib are scarcely known. We analyzed the disease progression during osimertinib treatment to identify potential treatment strategies. METHODS: We identified advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hye Sook, Lim, Kun Young, Lee, Soo‐Hyun, Kim, Hyae Young, Lee, Youngjoo, Han, Ji‐Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278531/
https://www.ncbi.nlm.nih.gov/pubmed/37096765
http://dx.doi.org/10.1002/cam4.5926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278531/
https://www.ncbi.nlm.nih.gov/pubmed/37096765
http://dx.doi.org/10.1002/cam4.5926

Ejemplares similares